Hugh Mostafid
@ahmostafid
Followers
769
Following
733
Media
26
Statuses
433
Bladder Cancer researcher, EAU NMIBC guidelines panel, Views my own
Guildford, England
Joined May 2014
Came across this by chance in Dubai - never realised that an NHS hospital had a ‘branch’ in Dubai + proudly boasts that many of the staff are recruited from the NHS. At a time of long w/lists, bed waits and low morale not sure this is what our NHS hospitals should be supporting.
0
0
13
RT @UroDocAsh: Thrilled that active surveillance for #BladderCancer has made it into #EAU23 Guidelines @Uroweb @paolo_gontero @MRoupret . W….
0
32
0
RT @EurUrolOncol: Editor's Choice: Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours. https://….
0
12
0
RT @EurUrolOncol: Bladder Cancer Review: Epidemiology, Screening, and Prevention of Bladder Cancer . . @niyatilobo….
0
35
0
RT @EurUrolOncol: Editor Pick: Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours . https://t.co….
0
8
0
RT @UroDocAsh: The evidence for role of neoadjuvant therapy in NMIBC continues to mount. 2 doses of NAC with MMC reduced risk of recurrence….
auajournals.org
Purpose:Intravesical mitomycin-C is recommended immediately after transurethral resection of bladder tumor for nonmuscle-invasive bladder cancer. However, a lack of compliance occurs due to the...
0
28
0
RT @UroDocAsh: I have used this strategy in patients unable to undergo TURBT (eg recovering from acute MI) or to debulk certain tumors prio….
0
2
0
RT @SkydtLindgren: Happy to share our preprint investigating chemoablation in recurrent non-muscle invasive bladder cancer. @JCO_ASCO @J….
ascopubs.org
Journal of Clinical Oncology (JCO) is a high-impact, peer-reviewed medical journal that publishes significant clinical oncology research along with editorials, reviews, and other works that relate to...
0
8
0
RT @siadaneshmand: Iranian women are among the most educated and accomplished around the world. Help support the movement #mahsaamini #wome….
instagram.com
0
27
0
RT @Heer_Lab: 10/ Massive thanks to the team @ahmostafid @ParamMariappan @UniofNewcastle @NCL_medresearch @ICR_London @EmmaHall71 @hsru_ab….
0
4
0
RT @UroDocAsh: Hyperthermic chemo does not improve DFS in intermediate risk NMIBC: DFS @ 24 mos: 61% vs 60% . Conclusive results from HIVE….
0
39
0
RT @brianjlinder: Enjoyed presenting a didactic course: 'How to proceed with hematuria' w/ @ahmostafid at the #EAU22 meeting. Great intera….
0
2
0
RT @GGiannarini: #EAU22 Join us next Saturday for a terrific #ESOU #ERUS #ESUT session on controversies in uro-oncology. Crème de la crème….
0
10
0
2/2…I’m reaching out further afield. Very happy to collaborate on bladder cancer academic output and teaching with interested centres world wide. DM me +/- will be in Amsterdam at EAU. Thanks!.
1
1
6
1/2 I work in a non academic cancer centre but have a strong interest in research and teaching. Unfortunately this makes me an academic ‘orphan’. I’ve approached 5 academic centres in the UK including our local Uni to collaborate on research and/or teaching but no interest so….
6
2
16
RT @EdinBC_Surgery: Come join us in August for our inaugural workshop on Endoscopic Bladder Cancer Surgery @WghLothian #EBCSatEBCS @JoCress….
0
8
0
RT @EUplatinum: Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with….
0
18
0
RT @mrSinanK: Congratulations @stingrai78 @drimranomar @ahmostafid & co on this important systematic review of incidence & risk facto….
0
12
0
RT @BladderCancerUK: Thanks @OlympusMedUKIE for sharing this #HealthcareConvo about our top three priorities for #BladderCancer diagnosis,….
0
2
0
RT @UrowebESU: New #UROwebinar by Profs. @paolo_gontero, @ahmostafid & Van Rhijn next week! . Learn about new system that uses data from a….
0
8
0